These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 1975321

  • 1. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Lancet; 1990 Jul 14; 336(8707):65-71. PubMed ID: 1975321
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul 14; 336(8707):71-5. PubMed ID: 1975322
    [Abstract] [Full Text] [Related]

  • 4. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar 28; 339(8796):753-70. PubMed ID: 1347801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A, Mauri F, Maggioni AP, Franzosi MG, Santoro L, De Vita C.
    G Ital Cardiol; 1995 Mar 28; 25(3):353-64. PubMed ID: 7642042
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH, O'Donnell CJ, Ridker PM, Marder VJ.
    J Am Coll Cardiol; 1995 Jun 28; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [Abstract] [Full Text] [Related]

  • 14. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
    Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Sontoro E, Tavazzi L, Tognoni G.
    J Am Coll Cardiol; 1994 Sep 28; 24(3):608-15. PubMed ID: 8077528
    [Abstract] [Full Text] [Related]

  • 15. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).
    Maggioni AP, Franzosi MG, Farina ML, Santoro E, Celani MG, Ricci S, Tognoni G.
    BMJ; 1991 Jun 15; 302(6790):1428-31. PubMed ID: 2070108
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base.
    Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G.
    Circulation; 1993 Aug 15; 88(2):416-29. PubMed ID: 8339405
    [Abstract] [Full Text] [Related]

  • 18. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G, Teodorescu C, Dan M, Guran M, Căpraru P, Istrăţescu O, Tatu-Chiţoiu A, Bumbu A, Chioncel V, Arvanitopol S, Dorobanţu M.
    Rom J Intern Med; 2004 Aug 15; 42(3):557-73. PubMed ID: 16366130
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Tissue-type plasminogen activator (t-PA): comments on results of the GISSI-2 study].
    Turazza FM.
    Medicina (Firenze); 1990 Aug 15; 10(2):193-4. PubMed ID: 2125681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.